At a glance
- Originator Bayer Schering Pharma
- Class Antiemetics
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 17 Jun 1999 New profile
- 17 Jun 1999 Discontinued-II for Stroke in Europe (Unknown route)